Sidoti Events, LLC's Virtual May Micro-Cap Conference

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 8-9, 2024. The presentation schedule is subject to change. Please visit www.sidoti.comevents for the most updated version and webinar links

Presentation Schedule

*All Times EST

Wednesday, May 8, 2024 (Day 1)

8:30-9:00

Perfect Corp (PERF)

*****

Evaxion (EVAX)

9:15-9:45

CPS Technologies Corp. (CPSH)

*****

Talisker Resources Ltd. (TSKFF)

10:00-10:30

Genius Group (GNS)

L.B. Foster (FSTR)

Alico Inc. (ALCO)

10:45-11:15

AstroNova, Inc. (ALOT)

*****

Athira Pharma (ATHA)

11:30-12:00

*****

Apogee Enterprises, Inc. (APOG)

MDU Resources Group, Inc. (MDU)

12:15-12:45

ZYUS Life Sciences Inc. (ZYUS)

Forum Energy Technologies (FET)

Flexsteel Industries, Inc. (FLXS)

1:00-1:30

NCS Multistage (NCSM)

Innovative Solutions & Support (ISSC)

LifeVantage Corporation (LFVN)

1:45-2:15

American Public Education (APEI)

*****

Cherry Hill Mortgage Investment Corp. (CHMI)

2:30-3:00

*****

Volato Group, Inc. (SOAR)

Lee Enterprises Inc (LEE)

3:15-3:45

*****

Solaris Oilfield Infrastructure (SOI)

Genprex, Inc. (GNPX)

4:00-4:30

AppTech Payments Corp. (APCX)

*****

HF Foods Group Inc. (HFFG)

1x1s Only

(8th)

Bassett Furniture (BSET)

Civeo Corporation (CVEO)

Manitex International (MNTX)

*All Times EST

Thursday, May 9, 2024 (Day 2)

9:15-9:45

ZOOZ Power Ltd. (ZOOZ)

FendX Technologies (FDXTF)

*****

10:00-10:30

Anterix (ATEX)

*****

Mistras Group (MG)

10:45-11:15

LeddarTech Holdings, Inc. (LDTC)

*****

Regional Management (RM)

11:30-12:00

Synchronoss Technologies (SNCR)

Wealth Minerals LTD (WML)

Anixa Biosciences, Inc. (ANIX)

12:15-12:45

Union Jack Oil plc (UJO)

Global Crossing Airlines Group (JET)

Spectral AI (MDAI)

1:00-1:30

Owlet, Inc. (OWLT)

Vince Holding Corp. (VNCE)

*****

1:45-2:15

Sato Technologies Corp (SATO)

*****

FitLife Brands, Inc. (FTLF)

2:30-3:00

Calidi Biotherapeutics, Inc. (CLDI)

*****

TruGolf Holdings, Inc. (TRUG)

1x1s Only

(9th)

Beazer Homes (BZH)

Gulf Island Fabrication (GIFI)

*****

About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
In 2023, Sidoti & Company, LLC (www.sidoti.com) formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater than 50 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. In 2024, Sidoti established Lighthouse Equity Research as an extension of its CSR program to meet the specific needs of companies not valued using traditional metrics or that face challenges obtaining coverage due to political risks or other factors. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

SOURCE: Sidoti Events, LLC



View the original press release on accesswire.com

News Provided by ACCESSWIRE via QuoteMedia

ATHA
The Conversation (0)
Athena Gold Corporation Announces Increase in Private Placement and Closes Second Tranche

Athena Gold Corporation Announces Increase in Private Placement and Closes Second Tranche

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNR) ("Athena" or the "Company") is pleased to announce that due to strong demand, the Company has increased the size of the non-brokered private placement previously announced on October 3, 2024, from CDN $1,000,000 to up to CDN $1,250,000 (the "Offering"). The Offering, as amended, will now consist of up to 25,000,000 units (the "Units") (increased from 20,000,000 Units) at a price of CDN $0.05 per Unit. All other terms of the Offering remain unchanged

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
SAGA Metals Reports Channel Sample Assay Results at Double Mer Uranium Project

SAGA Metals Reports Channel Sample Assay Results at Double Mer Uranium Project

Saga Metals Corp. ("SAGA" or the "Company"), a North American exploration company focused on critical mineral discovery in Canada, is pleased to share the channel sample assay results from its inaugural field program at the Double Mer Uranium Project, located in eastern Labrador, Canada.

Key Channel Sample Assay Highlights:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
SAGA Metals Reports Assay Results and Plans Drill Program at Double Mer Uranium Project

SAGA Metals Reports Assay Results and Plans Drill Program at Double Mer Uranium Project

Saga Metals Corp. ("SAGA" or the "Company"), a North American exploration company focused on critical mineral discovery in Canada, is pleased to share assay results from its inaugural field program at the Double Mer Uranium Project, located in eastern Labrador, Canada.

Key Updates from the Double Mer Uranium Project

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Canadian Securities Exchange Reports October 2024 Performance Figures

Canadian Securities Exchange Reports October 2024 Performance Figures

The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for October 2024.

October 2024 Operating Statistics

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
SAGA Metals Prepares Maiden Drill Program at Double Mer Uranium Project

SAGA Metals Prepares Maiden Drill Program at Double Mer Uranium Project

Saga Metals Corp. (" TSXV: SAGA ") (" FSE: 20H" ) (" SAGA " or the " Company "), a North American exploration company focused on discovering critical minerals, is pleased to announce its plans for a maiden drill program at the Double Mer Uranium project.

Key Highlights for the maiden drill program at the Double Mer Uranium Project:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Invion Limited

Invion Doses First Patient in Phase I/II Non-Melanoma Skin Cancer Trial

Invion Limited (ASX: IVX) (“Invion” or the “Company”) is pleased to announce the dosing of the first patient in its Phase I/II non- melanoma skin cancer (NMSC) trial conducted at Veracity Clinical Research (Veracity) in Brisbane.

Keep reading...Show less
BPH Global

Seaweed Extraction of Critical Minerals R&D

BPH Global (BP8:AU) has announced Seaweed Extraction of Critical Minerals R&D

Download the PDF here.

Resonance Health Ltd

Resonance Contracted by Major Global Pharma Company for Clinical Drug Trial Worth $13.775 Million over 24 Months

Resonance Health Ltd (ASX: RHT) (Resonance or the Company) advises that it has been contracted by Sun Pharmaceutical Industries Limited, an international, publicly listed pharmaceutical company with global operations (Customer) to be the local Australian sponsor, and to provide clinical research organisation (CRO) services, trial site services, and imaging analysis services (collectively, Services), for their clinical trial in Australia of a new drug compound (Clinical Trial).

Keep reading...Show less
  Island Pharmaceuticals

ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update

Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b clinical trial in dengue fever.

Keep reading...Show less

Latest Press Releases

Related News

×